Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Br J Dermatol ; 168(3): 555-62, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23136927

ABSTRACT

BACKGROUND: Drug patch tests (PTs) can reproduce delayed hypersensitivity to drugs and entail a moderate re-exposure of patients to offending drugs. OBJECTIVES: To determine the value of PTs for identifying the responsible drug in severe cutaneous adverse drug reactions (SCARs) such as acute generalized exanthematous pustulosis (AGEP), drug reaction with eosinophilia and systemic symptoms (DRESS) and Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN). METHODS: In a multicentre study, PTs were conducted on patients referred for DRESS, AGEP or SJS/TEN within 1 year of their SCAR. All drugs administered in the 2 months prior to and the week following the onset of the SCAR were tested. RESULTS: Among the 134 patients included (48 male, 86 female; mean age 51·7 years), positive drug PTs were obtained for 24 different drugs. These included positive tests for 64% (46/72) of patients with DRESS, 58% (26/45) of those with AGEP and 24% (4/17) of those with SJS/TEN, with only one relapse of AGEP. The value of PTs depended on the type of drug and the type of SCAR (e.g. carbamazepine was positive in 11/13 DRESS cases but none of the five SJS/TEN cases). PTs were frequently positive for beta lactams (22 cases), pristinamycin (11 cases) and in DRESS with pump proton inhibitors (five cases), but were usually negative for allopurinol and salazopyrin. Of 18 patients with DRESS, eight had virus reactivation and positive PTs. In DRESS, multiple drug reactivity was frequent (18% of cases), with patients remaining sensitized many years later. CONCLUSIONS: PTs are useful and safe for identifying agents inducing SCAR.


Subject(s)
Drug Eruptions/diagnosis , Acute Generalized Exanthematous Pustulosis/chemically induced , Adolescent , Adult , Aged , Aged, 80 and over , Drug Eruptions/etiology , Drug Interactions , Eosinophilia/chemically induced , Female , Humans , Male , Middle Aged , Patch Tests/adverse effects , Patch Tests/methods , Stevens-Johnson Syndrome/chemically induced , Stevens-Johnson Syndrome/etiology , Time Factors , Young Adult
2.
J Mal Vasc ; 36(6): 348-54, 2011 Dec.
Article in French | MEDLINE | ID: mdl-22015041

ABSTRACT

Diagnosis of superficial vascular anomalies, previously called "angiomas", is basically clinical. Ultrasound and duplex Doppler imaging is a simple and helpful tool to confirm the clinical diagnosis and/or to suggest further required imaging modalities. The purpose of this work is to demonstrate the usefulness of duplex Doppler and ultrasound for exploring vessel and soft tissue components of vascular anomalies.


Subject(s)
Hemangioma/diagnostic imaging , Arteriovenous Malformations/diagnostic imaging , Blood Vessels/abnormalities , Hemangioma/congenital , Humans , Lymphatic System/abnormalities , Ultrasonography, Doppler, Color , Vascular Neoplasms/diagnostic imaging
3.
Photodermatol Photoimmunol Photomed ; 23(6): 215-21, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17986056

ABSTRACT

BACKGROUND: Treatments currently used in acrosclerosis for patients with systemic sclerosis (SS) are not very efficient and are associated with adverse effects. Several reports concern the efficacy of ultraviolet A1 (UVA1) phototherapy for localized scleroderma. Recent studies appear to indicate the interest of UVA1 in acrosclerosis for patients with SS. However, these studies are uncontrolled. OBJECTIVE: To determine whether UVA1 phototherapy is effective for acrosclerosis in SS with a randomized, investigator-blinded, controlled study. METHODS: Nine patients with SS completed the study. The duration of disease ranged from 6 to 21 years. None of them had received glucocorticoids or immunosuppressive agents. Low-dose UVA1 phototherapy (40 J/cm(2)) of the randomized hand was performed three times weekly over a period of 14 weeks. The other hand served as control. The clinical evaluation used a modified semiquantitative skin scoring system, the index flexion and extension, and a visual analog scale (VAS) was performed at baseline and after treatment. RESULTS: The mean of skin score and VAS improved significantly (P<0.05), but this improvement does not appear to be different between the treated or the untreated hands. There was no modification of the index flexion or extension. Two patients noticeably improved the functions of the treated hand. No side effects were observed. CONCLUSIONS: These results suggest that UVA1 phototherapy does not improve cutaneous thickness in acrosclerosis even if few functional improvements, and some ulcerations healings can be occasionally observed. However, a larger scale trial is necessary to confirm this inefficiency.


Subject(s)
Scleroderma, Systemic/pathology , Scleroderma, Systemic/radiotherapy , Ultraviolet Therapy , Aged , Female , Humans , Male , Middle Aged , Wound Healing/radiation effects
SELECTION OF CITATIONS
SEARCH DETAIL
...